| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr VP, Clinic Development
1 company
Roberts Brian Kenneth serves as a Chief Medical Officer at RZLT. Across recent SEC filings that breaks down to 19 buys and 0 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Roberts Brian Kenneth's trades have earned a strong insider score of 79/100 across 15 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +37.7%.
The biggest single holding is RZLT (~$1.5M) as Chief Medical Officer. Net of sales, the recent Form 4 record there shows accumulation of 99,152 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | RZLT Rezolute, Inc. | Sr VP, Clinic Development | Buy | 1,500 | $3.24 | $4,862.25 | +7.1% | +6.3% | -28.7% | |
| May 4, 2022 | RZLT Rezolute, Inc. | Sr VP, Clinic Development | Buy | 21,052 | $3.80 | $79,997.60 | New | -16.4% | -43.5% |